How to Profit from Compound Management Know-How?




Oliver Peter, PhD, Group Head of Drug Discovery Biology at HTS Group, Actelion Pharmaceuticals, joins Pharma IQ, to discuss compounds and biosamples and materials management.In this interview Peter covers biosample stabilisation, optimum data structures to store biosample information, challenges associated with low temperature storage and how to profit from compound management know-how.

[inlinead]

This interview was conducted at IQPC's 8th Compound Management & Integrity event in May 2011.

Have Your Say
Rate this feature and give us your feedback in the comments section below
Oliver Peter, PhD, Group Head of Drug Discovery Biology at HTS Group, Actelion Pharmaceuticals, joins Pharma IQ, to discuss compounds and biosamples and materials management.In this interview Peter covers biosample stabilisation, optimum data structures to store biosample information, challenges associated with low temperature storage and how to profit from compound management know-how.
TO READ THE FULL STORY